Brief: Novan reports Q2 results

NVN Liquidation

11/08/2022 11:34

Aug 11 (Reuters) - Novan Inc  NOVN.O :
    * NOVAN REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES
CORPORATE UPDATE
    * Q2 REVENUE $6.2 MILLION
    * ACTIVITIES ON TRACK FOR SUBMISSION OF BERDAZIMER GEL,
10.3%
(SB206) NEW DRUG APPLICATION (NDA), TARGETING SUBMISSION BEFORE
END OF 2022
    * NOVAN - QTRLY LOSS PER SHARE $0.44
    * Q2 EARNINGS PER SHARE VIEW $-0.57, REVENUE VIEW $6.4
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX988hhw 
Further company coverage:  NOVN.O